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tumour necrosis superfamily
member RANKL
Humberto Gutierrez†,‡, Lilian Kisiswa†, Gerard W. O’Keeffe},
Matthew J. Smithen, Sean Wyatt and Alun M. Davies
Cardiff School of Biosciences, Cardiff University, Cardiff Wales CF10 3AX, UK1. Summary
RANKL (receptor-activator of NF-kB ligand, TNFSF11) is a member of the TNF
superfamily that regulates bone remodelling and the development of the
thymus, lymph nodes and mammary glands. While RANKL and its membrane
bound receptor RANK (TNFRSF11A) are expressed in the adult central nervous
system and have been implicated in thermoregulation, the potential function of
RANK signalling in the developing nervous system remains unexplored. Here,
we show that RANK is expressed by sympathetic and sensory neurons of
thedevelopingmouseperipheralnervous systemand that activatingRANKsignal-
ling in these neurons during perinatal development by either treating cultured
neurons with soluble RANKL or overexpressing RANK in the neurons inhibited
neurotrophin-promoted neurite growthwithout affecting neurotrophin-promoted
neuronal survival. RANKL is expressed in tissues innervated by these neurons,
and studies in compartment cultures demonstrated that RANKL is capable of
acting directly on neurites to inhibit growth locally. Enhancing RANK signalling
in cultured neurons resulted in NF-kB activation and phosphorylation of the p65
NF-kB subunit on serine 536. Transfecting neuronswith a series ofmutated signal-
ling proteins showed that NF-kB activation and p65 phosphorylation occurred by
an IKKb-dependent mechanism and that blockade of this signalling pathway
prevented neurite growth inhibition by RANKL. These findings reveal that
RANKL is a novel negative regulator of neurite growth from developing PNS
neurons and that it exerts its effects by IKKb-dependent activation of NF-kB.2. Introduction
The growth and guidance of axons in the developing nervous system is regu-
lated by numerous extracellular signals that either promote or inhibit axon
extension and influence axon trajectory by acting as either attractants or repel-
lents at the growth cone [1]. The sympathetic neurons of the developing mouse
superior cervical ganglion (SCG) are an extensively studied, experimentally
tractable population of neurons for investigating the regulation of axonal
growth and target field innervation in the peripheral nervous system [2,3].
A variety of secreted signalling proteins have been shown to promote sympath-
etic axon growth, including nerve growth factor (NGF), neurotrophin-3 (NT_3),
glial cell-derived neurotrophic factor (GDNF), artemin and hepatocyte growth
factor (HGF). Of these, the most extensively studied and best understood is
NGF, which is produced in the tissues innervated by these neurons, and which
promotes the growth and branching of sympathetic axons within these tissues
[4]. Target-derived NGF also has a well-established role in promoting and regu-
lating sympathetic neuron survival during development [5]. In addition to
factors that promote growth and branching, brain-derived neurotrophic factor
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[6] and to play a role in the axon pruning that establishes
regional differences in innervation density [7].
To identify additional candidate extracellular regulators of
sympathetic axonal growth, we carried out a QPCR screen for
the expression of known families of receptors in the developing
SCG at stages of development from initial axon extension to
establishment of target field innervation. Among the receptor
transcripts expressed at high levels was that for RANK (recep-
tor-activator of NF-kB, TNFRSF11A), a member of the tumour
necrosis factor (TNF) receptor superfamily. The 19 members
of the TNF superfamily of ligands are best understood for
their many critical functions in the development and function
of the immune system, and are increasingly recognized as
having diverse roles in other tissues and organs [8]. These cyto-
kines are type II transmembrane glycoproteins that are active
both as membrane-bound ligands and as soluble ligands fol-
lowing cleavage from the cell membrane by the action of
specific metalloproteinases. TNFSF ligands bind to one or
more members of the TNF receptor superfamily, which are
classified into three groups: those containing a proapoptotic
death domain, those lacking a death domain and a group of
decoy receptors that do not transmit any signal [9].
RANK lacks a death domain and interacts with adaptors
of the TRAF family to modulate several signalling pathways,
including the NF-kB signalling pathway [10]. RANK and its
ligand RANKL play essential roles in the immune system,
where they regulate dendritic cell survival and maturation,
lymphocyte differentiation, and T-cell responses [11]. RANK
signalling is also a crucial regulator of bone turnover by con-
trolling osteoclast differentiation and activation [12], and is
important for the formation of lobulo-alveolar mammary
structures during pregnancy [13]. Osteoprotegerin (OPG),
a decoy receptor for RANKL, competes with RANK for
binding to RANKL, thereby negatively regulating RANK sig-
nalling [14]. RANKL and RANK are also expressed in the
central nervous system [15], where they have been implicated
in thermoregulation and the central fever response to inflam-
mation [16]. However, the potential role of RANK signalling
in neuronal development has not been explored. Here we
report a novel function for RANKL as a potent negative reg-
ulator of neurotrophin-promoted neurite growth, but not
survival, in sympathetic and sensory neurons of developing
peripheral neurons, and show that this effect is mediated
by a mechanism involving canonical NF-kB signalling.3. Results
3.1. RANK is expressed in developing superior cervical
ganglion neurons
To identify members of the TNF superfamily that may play a
role in regulating axon growth, we carried out a real-time
PCR screen for expression of the receptors for this superfamily
in the mouse SCG at stages throughout embryonic and early
post-natal developmentwhen axons are growing to and ramify-
ing within their targets. This screen revealed prominent
expression of RANK mRNA, with a sixfold increase in the
level of expression between E14 and P5 relative to the reference
mRNAs encoding the housekeeping proteins glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) and succinate
dehydrogenase (SDHA; figure 1a). This spans the period ofdevelopment from neurogenesis to the establishment of target
field innervation [3]. To confirm expression of RANK protein
and determine which cells express RANK protein, we used
immunocytochemistry to localize RANK in dissociated cell cul-
tures established from the SCG of newborn mice. These studies
showed that the cell bodies and processes of all neurons (posi-
tively identified with an anti-bIII tubulin antibody) were
labelled by a specific anti-RANK antibody, and that non-
neuronal cells were unlabelled by this antibody (figure 1b).
High-power confocal optical sections through the cell body
showed predominantly membrane labelling (figure 1d). No
cells were labelled when primary antibodies were omitted
from the protocol (not shown).
3.2. RANKL impairs nerve growth factor-promoted
neurite growth from developing superior cervical
ganglion neurons
Having found especially high levels of RANK mRNA in the
SCG during the stages of development when SCG axons are
growing and branching in their targets and the neurons
are additionally dependent on target-derived signals such as
NGF for their survival, we investigated whether RANK signal-
ling plays a role in regulating axonal growth and/or neuronal
survival. To do this, we studied the effect of purified recombi-
nant RANKL on neurite growth and neuronal survival in
low-density dissociated cultures of newborn (P0) SCG neurons.
In the absence ofNGF, the greatmajorityof neurons diedwithin
24 h of plating, and RANKL neither enhanced survival nor pro-
moted neurite growth from the small number of neurons that
had not undergone apoptosis by 24 h (data not shown). Because
RANKL alone had no obvious effect on SCGneurons,we inves-
tigatedwhether it modulates the effects ofNGFon survival and
neurite growth. In NGF-supplemented cultures, more than 80
per cent of P0 SCG neurons survived and elaborated extensive
neurite arbours within 24 h of plating. The addition of RANKL
to NGF-supplemented cultures had no significant effect on
neuronal survival (data not shown), but markedly reduced
the size and complexity of neurite arbours (figure 1c,e). This
obvious reduction in neurite growth was confirmed by quanti-
fication of total neurite length and number of branch points,
and by Sholl analysis, which provides a graphical illustration
of neurite length and branching with distance from the cell
body (figure 1f,g). To test the specificityofRANKL–RANKinter-
action inRANKLsuppressionofNGF-promotedneurite growth,
we studied the effects of specific competitors of RANKL–RANK
interaction. Both the naturally occurring decoy receptor OPG
(figure 1f ) and a recombinant soluble RANKfc chimeric protein
(figure 1g) completely prevented the inhibitory effect of RANKL
on NGF-promoted neurite growth. These results suggest
that binding of RANKL to RANK triggers a neurite growth
inhibitory signal in developing sympathetic neurons.
3.3. RANK signalling impairs nerve growth factor-
promoted neurite growth from superior cervical
ganglion neurons over an extended period
of development
To determine whether the inhibitory effect of RANK signal-
ling on NGF-promoted neurite growth is restricted to a
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Figure 1. RANK is expressed in developing SCG neurons and its activation inhibits NGF-promoted neurite growth. (a) Levels of RANK mRNA relative to the reference
mRNAs, GAPDH and SDHA, in RNA extracted from SCG at ages ranging from E14 to P5. The mean+ s.e.m. of data obtained from four separate sets of ganglia at
each age are shown. (b) Photomicrographs of a P0 SCG neuron immunostained for RANK and b-III tubulin after 24 h incubation in medium containing 10 ng ml–1
NGF. Scale bar ¼ 10 mm. A non-neuronal cell whose nucleus, along with the neuronal nucleus, is stained with the nuclear marker DAPI was unlabelled by the anti-
RANK antibody. (c) Representative photomicrographs of P0 SCG neurons labelled with calcein AM after 24 h incubation in medium containing either 10 ng ml21
NGF or NGF plus 10 ng ml– 1 recombinant RANKL. (d ) Confocal optical section through a neuron cell body. Scale bar ¼ 10 mm. (e) Representative camera lucida
drawings of neurons illustrating the range of morphologies of P0 SCG neurons after 24 h incubation in medium containing either NGF or NGF plus RANKL. The
neurons illustrated correspond to percentiles 25, 50, 75 and 100 of the sampled populations in terms of total neurite length. Scale bar ¼ 20 mm. ( f,g) Sholl
profiles, total length and number of branching points in the neurite arbours of P0 SCG neurons incubated for 24 h in medium containing 10 ng ml21 NGF alone,
NGF plus 10 ng ml– 1 RANKL or NGF plus RANKL plus either ( f ) 10 ng ml21 OPG or (g) 10 ng ml– 1 RANKfc. To facilitate comparison of separate experiments, the
length and branching point data are expressed as a percentage of the NGF values. Mean+ s.e.m. are shown, **p, 0.001, statistical comparison with NGF data.
The non-normalized neurite length and branching datasets for all experiments carried out are provided in electronic supplementary material, spreadsheet S1.
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RANKL on neurite growth from SCG neurons cultured at
stages throughout post-natal development. Sholl analysisrevealed that RANKL reduced the size and complexity of
the neurite arbours of SCG neurons grown with NGF from
P0 to at least P10 (figure 2a). We additionally studied the
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Figure 2. Recombinant RANKL and RANK overexpression impair NGF-promoted neurite growth from SCG neurons over an extended period of development. (a) Sholl
profiles of SCG neurons isolated from (i) P0, (ii) P5 and (iii) P10 mice after 24 h incubation with either 10 ng ml21 NGF (unfilled circles) or NGF plus 10 ng ml21
RANKL (filled circles). (b) Sholl profiles of SCG neurons isolated from (i) P0, (ii) P5 and (iii) P10 mice that were incubated for 24 h in medium containing 10 ng ml21
NGF after transfection with a YFP expression plasmid together with either an empty control plasmid (control, unfilled circles) or a YFP expression plasmid together a
plasmid expressing RANK (filled circles). Means+ s.e.m. of typical experiments are shown at each age. The neurite length and branching datasets for all
experiments carried out are provided in electronic supplementary material, spreadsheet S2.
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overexpressing RANK in these neurons by transfecting
them with a plasmid that expresses RANK. Sholl analysis
showed that neurite arbours of neurons overexpressing
RANK were markedly smaller and less branched than
those of control-transfected neurons in NGF-supplemented
medium over this period of development (figure 2b). These
results demonstrate that enhancing RANK signalling impairs
NGF-promoted neurite growth from SCG neurons over an
extended period of post-natal development.
3.4. RANKL is expressed in targets and acts locally on
sympathetic axons to inhibit growth
To investigate the developmental context in which RANKL
might influence the SCG neuron development and modulate
the innervation of sympathetic targets, we asked whether
RANKL is expressed in SCG target tissues at stages through-
out the period of development when sympathetic axons are
growing and branching within these targets. To this end,
we quantified RANKL mRNA levels in two anatomically dis-
crete and easily dissectable target tissues: the submandibular
gland and the pineal gland. During the immediate post-natal
period, there was a gradual increase in the expression of
RANKL mRNA in the submandibular gland, reaching a
peak by P10 (figure 3a), and a sustained expression of
RANKL mRNA in the pineal gland, although a transient
peak was evident at P5 (figure 3c). Histological sections
through the submandibular gland showed RANKL immu-
noreactivity in the parenchyma of this gland (figure 3b).
These findings raise the possibility that RANKL could act
on SCG axons within their target tissues.To assess whether RANKL is capable of exerting a local
inhibitory effect on the growth of sympathetic axons, we cul-
tured SCG neurons in microfluidic devices in which the cell
bodies and neurites are grown in separate compartments,
permitting independent experimental manipulation of the
environment in each compartment. P0 SCG neurons were
seeded into one compartment (the cell body compartment)
that was supplemented with NGF to maintain neuronal via-
bility. The other compartment (the neurite compartment)
received either NGF alone or NGF plus RANKL. After
24 h incubation, the neurite arbours and cell bodies of
neurons that extended neurites into the neurite compartment
were labelled with calcein AM added to the neurite com-
partment. Average neurite length per labelled soma was
estimated by counting intersections between all neurites
and a series of equally spaced parallel lines digitally traced
in the neuritic compartment. Addition of RANKL to the
neurite compartment caused a highly significant decrease in
neurite length compared with neurites growing with NGF
alone (figure 3d,e). Taken together, these results show that
RANKL is expressed in sympathetic targets, and can poten-
tially act on sympathetic axons to restrict their extension and
branching locally.3.5. RANKL/RANK signalling enhances NF-kB
transcriptional activity in superior cervical ganglion
neurons
Because the NF-kB transcription factor complex plays a role
in mediating several of the cellular responses to members
of the TNFSF, including RANK [9,10], and NF-kB signalling
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Figure 3. RANKL is expressed in sympathetic targets and acts directly on sympathetic axons to suppress NGF-promoted growth. (a) Levels of RANKL mRNA relative
to GAPDH and SDHA mRNAs in RNA extracted from submandibular gland at ages ranging from P0 to P10. The mean+ s.e.m. of data obtained from four separate
sets of glands at each age are shown. (b) Immunohistochemical localization of RANKL in a section through the submandibular gland at P0. A section incubated with
secondary antibody alone (control) is also shown. Scale bar ¼ 50 mm. (c) Levels of RANKL mRNA relative to GAPDH and SDHA mRNAs in RNA extracted from pineal
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we investigated the potential role of NF-kB in mediating
the neurite growth inhibitory effect of RANKL/RANK
signalling. First, we tested whether RANKL and RANK
signalling enhance NF-kB transcriptional activity in SCG
neurons. The level of NF-kB transcriptional activity was
measured by transfecting P0 SCG neurons with a reporter
construct in which GFP expression is under the control of a
series of kB regulatory elements [18]. The neurons were
then plated in NGF-containing medium with and without
RANKL. The NF-kB reporter signal was quantified in the
transfected neurons after 4 and 24 h in culture. RANKL
stimulation resulted in significant increases in the reporter
signal at both time points, but especially after 4 h of
RANKL stimulation (figure 4a). Enhancing RANK signalling
by overexpressing RANK in the neurons by transfecting them
with a RANK expression plasmid also enhanced the NF-kB
reporter signal, although NF-kB transcriptional activity was
sustained in RANK transfected neurons throughout the
24 h culture period (figure 4b). These results show that
RANK signalling enhances NF-kB transcriptional activity in
developing SCG neurons.3.6. Neurite growth inhibition by RANK signalling
requires IKKb- (but not IKKa-) mediated NF-kB
activation
To assess the role of NF-kB in neurite inhibition brought
about by RANK signalling, we studied the magnitude of
NGF-promoted neurite growth from P0 SCG neurons co-
transfected with the RANK expression plasmid and plasmids
expressing mutated proteins that interfere with key steps in
NF-kB signalling and activation. RANK overexpression was
used to dissect steps in NF-kB signalling required for neurite
growth inhibition because this gives prolonged activation of
NF-kB and has a proportionally greater effect on neurite
growth inhibition, so the effects of manipulating different
steps in NF-kB signalling on the magnitude of neurite
growth inhibition are easier to observe.
In the canonical NF-kB signalling pathway, the NF-kB
inhibitory protein IkBa is phosphorylated by the IKKb sub-
unit of an IkB kinase (IKK) complex, resulting in its
ubiquitination and proteasome-mediated degradation. Fol-
lowing IkBa degradation the p65/p50 NF-kB heterodimer,
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Figure 4. Recombinant RANKL and RANK overexpression activate NF-kB in
SCG neurons. (a) NF-kB reporter signal in P0 SCG neurons incubated for 4
and 24 h in medium containing 10 ng ml21 NGF alone (unfilled bars) and
10 ng ml– 1 NGF plus 10 ng ml– 1 RANKL (filled bars). (b) NF-kB reporter
signal in P0 SCG neurons transfected with either a RANK (filled bars)
expression plasmid or a control (unfilled bars) empty plasmid and incubated
for 4 and 24 h in medium containing 10 ng ml–1 NGF. The data are
normalized to the respective control signal. Mean+ s.e.m. are shown,
**p, 0.001, statistical comparison with the respective controls. The non-
normalized datasets of these experiments are provided in electronic
supplementary material, spreadsheet S4.
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IkBa, translocates to the nucleus, where it binds to kB
elements in the promoter and enhancer regions of responsive
genes. In the non-canonical NF-kB signalling pathway,
the p100 subunit of the p100/RelB NF-kB heterodimer is
phosphorylated by the IKKa subunit of the IKK complex,
resulting in ubiquitination and proteosome-dependent
processing of p100 to p52, followed by translocation of
the resulting p52/RelB heterodimer to the nucleus [19].
Expression of a dominant-negative IKKa protein (K44A-
IKKa) in SCG neurons had no effect on the magnitude
of NGF-promoted neurite growth compared with control-
transfected neurons and did not affect the suppression of
NGF-promoted neurite growth by RANK overexpression
(figure 5a). This suggests that IKKa plays no role in the
suppression of NGF-promoted neurite growth by RANK sig-
nalling. In marked contrast, expression of dominant-negative
IKKbprotein (K44A-IKKb) in SCGneurons completely reversed
the suppression of NGF-promoted neurite growth caused
by RANK overexpression, while having no effect on NGF-
promoted neurite growth when expressed alone (figure 5b).
This suggests that IKKb (but not IKKa) is required for
RANK-induced suppression of NGF-promoted neurite growth.
To test further the requirement for canonical NF-kB
signalling in RANK-mediated neurite growth inhibition, we
transfected P0 SCG neurons with a plasmid that expresses amutated IkBa protein that has serine-to-alanine substitutions
at residues phosphorylated by IKKb. As previously reported
[20], this S32A/S36A IkBa mutant affected neither NGF-
promoted neurite growth (figure 5c) nor NGF-promoted
survival (not shown). However, when the S32A/S36A IkBa
plasmid was co-transfected with the RANK plasmid, it
completely prevented the inhibitory effect of the latter on
NGF-promoted neurite growth (figure 5c), suggesting that
serine phosphorylation of IkBa (and hence canonical acti-
vation of NF-kB) is critical for neurite growth inhibition
associated with RANK overexpression.
3.7. Phosphorylation of p65 at serine 536 is required for
neurite growth inhibition by RANK signalling
We have recently shown that activated NF-kB can either pro-
mote or inhibit neurite growth depending on the activation
mechanism and the phosphorylation status of the p65
NF-kB subunit [20]. In addition to phosphorylating IkBa on
serines 32 and 36, activated IKKb has been shown to phos-
phorylate p65 on serine 536 [21–24], resulting in a neurite
growth-inhibiting form of the activated p65/p50 heterodimer
[20]. To ascertain whether treatment of SCG neurons with
RANKL leads to phosphorylation of p65 on S536, Western
analysis was carried on lysates of P0 SCG neurons that had
been treated with RANKL for different times following over-
night pre-incubation with NGF. This analysis revealed a
significant increase in the level of phospho-S536-p65 relative
to total p65 within 15 min of RANKL treatment, followed by
a further gradual rise in the level of phospho-S536-p65 over
60 min (figure 6a). To test whether p65 phosphorylation on
S536 is required for neurite growth inhibition associated
with RANK overexpression, we studied the effect of trans-
fecting P0 SCG neurons with a plasmid that expresses a
S536A-p65 mutant, which prevents phosphorylation at S536
without interfering with transcriptional activity [21,25,26].
This S536A-p65 mutant did not significantly affect NGF-
promoted neurite growth when expressed alone, but
prevented the neurite growth inhibitory effect of RANK
overexpression (figure 6b–d). This suggests that p65 phos-
phorylation at serine 536 is required for neurite growth
inhibition induced by RANK signalling.
3.8. RANK signalling suppresses neurite growth from
developing sensory neurons
To investigate whether RANK signalling exerts an inhibitory
effect on neurite growth from other populations of develop-
ing neurons, we studied two other experimentally tractable
populations of developing peripheral neurons: the NGF-
dependent neurons of the trigeminal ganglion and the
BDNF-dependent neurons of the nodose ganglion. QPCR
showed that both ganglia express RANKmRNA, and revealed
an increase in the relative level of RANK mRNA throughout
embryonic and post-natal development (figure 7a,d). Treatment
with RANKL significantly reduced BDNF-promoted neurite
growth from P1 nodose neurons (figure 7b) and significantly
reduced NGF-promoted neurite growth from P1 trigeminal
neurons (figure 7e). In these cultures, more than 80 per cent
of the neurons survived with the respective neurotrophin and
the addition of RANKL to the medium did not affect survival
(not shown). Likewise, transfecting nodose and trigeminal
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BDNF-promoted (figure 7c) and NGF-promoted (figure 7f )
neurite growth compared with control-transfected neurons,
again without affecting survival (not shown). These results
suggest that RANK signalling negatively regulates neurotro-
phin-promoted neurite growth in several populations of
developing neurons without affecting neurotrophin-promoted
survival. Furthermore, expression of either K44A-IKKb or
S536A-p65 (but not K44A-IKKa) in sensory neurons comple-
tely prevented suppression of neurotrophin-promoted neurite
growth by RANK overexpression (data not shown), demon-
strating the general involvement of IKKb-dependent NF-kB
canonical signalling in RANK-mediated neurite growth
inhibition in both sympathetic and sensory neurons.4. Discussion
We have discovered that RANKL is a potent negative regu-
lator of axon growth and branching in the developingperipheral nervous system. Soluble RANKL and activation
of RANK signalling by overexpressing RANK markedly
reduced the size and complexity of the neurite arbours
of perinatal SCG sympathetic neurons and trigeminal
sensory neurons cultured with NGF, and nodose sensory
neurons cultured with BDNF. Neither RANKL nor RANK
overexpression affected the survival of these neurons with
neurotrophins, indicating that RANK signalling has a selec-
tive effect on neurotrophin-promoted axonal growth and
branching, but not survival. Detailed developmental studies
on SCG neurons indicated that RANKL and RANK over-
expression inhibit NGF-promoted neurite growth over an
extended period of post-natal development, from P0 to at
least P10. Throughout this period of development, the
axons of SCG neurons are growing and branching within
their target tissues under the influence of target-derived
NGF. Like NGF, RANKL is expressed in SCG target tissues
over this period of development. In two anatomically discrete
SCG target organs, the pineal and submandubular glands,
RANKL mRNA was clearly detected throughout early
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 on March 27, 2013rsob.royalsocietypublishing.orgDownloaded from post-natal development. Moreover, immunohistochemistry
confirmed the presence of RANKL protein in cells of the
target field. Thus, axon growth-promoting and growth-
inhibiting factors are expressed in the same tissues. Studies
using compartment cultures have clearly shown that NGF
acts directly on axons to promote the growth of only those
axon branches exposed to it [27]. Likewise, using compart-
ment cultures, we also show that RANKL acts directly on
axons to inhibit their growth. Thus, it is possible that the precise
cellular disposition of NGF and RANKL within tissues
might fine-tune the growth and branching, and hence the
specific distribution of axons and their terminals within these
tissues, by a combination of antagonistic growth-promoting
and growth-inhibitory influences. RANK-deficient mice are
embryonic lethal [11]; thus a conditional knockout approach
will be necessary in future work to clarify the in vivo role
of RANK signalling in regulating tissue innervation during
post-natal development.
RANK lacks a death domain and interacts with adaptors
of the TRAF family to modulate several signalling pathways,
including the NF-kB signalling pathway [10]. NF-kB signal-
ling has been shown to regulate axon and dendrite growthin the developing peripheral and central nervous system
[17]. Importantly, IKKb-dependent NF-kB activation, with
its attendant phosphorylation of the p65 NF-kB subunit on
serine 536, exerts a strong inhibitory influence on neurite
growth, whereas NF-kB activation via an alternative tyrosine
kinase-dependent mechanism promotes neurite growth [20].
Here we demonstrate that RANKL and RANK signalling pro-
mote IKKb-dependent NF-kB activation in both SCG and
nodose neurons, and cause a rapid increase in the levels of
phospho-S536-p65. Furthermore, transfecting these neurons
with plasmids that express mutated versions of NF-kB signal-
ling proteins has demonstrated that IKKb-dependent NF-kB
activation is responsible for RANK-mediated neurite growth
inhibition. Expression of a dominant-negative K44A-IKKb
mutant, but not a dominant-negative K44A-IKKamutant, pre-
vents RANK-mediated neurite growth inhibition, as does a
S32A/S36A IkBa mutant, which cannot be phosphorylated
by IKKb and hence cannot activate NF-kB. IKKb-dependent
NF-kB activation has also been shown to be responsible
for inhibition of NGF-promoted neurite growth from sym-
pathetic neurons by TNFa [20]. By contrast, inhibition of
BDNF-promoted neurite growth from nodose neurons by the
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transcriptional activity in these neurons [28]. In nodose
neurons, tyrosine kinase-dependent NF-kB activation and
dephosphorylation of p65 at ser536 contributes to BDNF-
promoted neurite growth [29]. Thus, it appears that the
TNFSF members that inhibit neurite growth may do so by
modulating NF-kB signalling in different ways.
The TNF superfamily has been increasingly implicated in
the regulation of neurite growth during development. In
addition to the inhibitory effects of RANKL reported here,
and the inhibitory effects of TNFa [20,30] and LIGHT [28],
certain other members of the TNF superfamily enhance
neurite growth. For example, FasL promotes neurite growth
from DRG explants [31], and increases neurite branching
from cultured hippocampal and cortical neurons [32];
and GITRL–GITR signalling enhances NGF-promoted neur-
ite growth from SCG neurons [33,34]. TNF superfamily
members exert their opposing effects on neurite growth
from various kinds of neurons over differing periods of
development. Whereas, for example, LIGHT and TNFa
exert their respective inhibitory effects on sympathetic and
sensory neurite growth over narrow developmental windows
in the immediate perinatal period [20,28], RANKL inhibits
the growth of sympathetic and sensory neurites over anextended period of post-natal development. Thus, a com-
plex picture is emerging of multiple members of the
TNF superfamily facilitating or inhibiting the growth and
branching of the neural processes of particular kinds of
neurons over distinctive periods of development. It is concei-
vable that the collective involvement of members of the TNF
superfamily in regulating neurite growth during develop-
ment form part of the array of extracellular signals that
orchestrate the distinctive patterns of growth and arbouriza-
tion of different subsets of axons required to establish
appropriate patterns of connectivity during the normal
course of development.5. Material and methods
5.1. Real-time QPCR
The levels of RANK and RANKL mRNAs were quanti-
fied relative to a geometric mean of mRNAs for the house-
keeping enzymes GAPDH and SDHA, in dissected tissue
by RT-QPCR [35]. Total RNA was extracted from whole
SCG and sympathetic target organs with the RNeasy Mini
extraction kit (Qiagen) and 5 ml was reverse transcribed, for
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tion according to the manufacturer’s instructions. A total of
2.0 ml cDNA was amplified in a 20 ml reaction volume using
Brilliant III ultrafast QPCR master mix reagents (Agilent).
QPCR products were detected using dual-labelled (FAM/
BHQ1) hybridization probes specific to each of the cDNAs
(MWG/Eurofins). The PCR primers were: RANKL forward,
50-ATA CAT GTG TAA GAC TAC TAA GAG AC 30 and
reverse, 50-AAT CTA ACA TCA CCT ATG GAC TTT AC -30;
RANK forward, 50-TTA AAC TAT TGG CTG TCT A-30 and
reverse, 50-AAC TCTATT CAT TCT TTC TTG-30; GAPDH for-
ward, 50-GAG AAA CCT GCC AAG TAT G-30 and reverse,
50-GGA GTT GCT GTT GAA GTC-30; SDHA forward,
50-GGA ACA CTC CAA AAA CAG-30 and reverse, 50-CCA
CAG CAT CAA ATT CAT-30. Dual-labelled probes were
RANKL, FAM-CCC ACG GTG TAT GAA ACT CAC AGC
C-BHQ1; RANK, FAM-ATT TCC CTG GCA CCT TCA
TTT-BHQ1; GAPDH, FAM-AGA CAA CCT GGT CCT CAG
TGT-BHQ1; SDHA, FAM-CCT GCG GCT TTC ACT TCT CT-
BHQ1. Forward and reverse primers were used at a concen-
tration of 150 nM each, and dual-labelled probes were used
at a concentration of 300 nM. PCR was performed using the
Mx3000P platform (Agilent) using the following conditions:
45 cycles of 958C for 12 s and 608C for 35 s. Standard curves
were generated in every 96-well plate, for each cDNA for
every real-time PCR run, by using serial threefold dilutions
of reverse transcribed spleen total RNA (Ambion). The stan-
dard curves allowed a numerical value to be assigned to the
levels of RANK, RANKL and reference cDNAs in each reverse
transcribed sample. Four separate dissections were performed
for each age.
5.2. Neuron culture
SCG, trigeminal and nodose ganglia dissected from CD1 mice
were trypsinized and plated at very low density (approx. 500
neurons per dish) in polyornithine/laminin-coated 35 mm
tissue culture dishes (Greiner) in serum-free Hams F14
medium [36] supplemented with 0.25 per cent Albumax I
(Invitrogen). Neuronal survival was estimated by counting
the number of attached neurons within a 12  12 mm grid in
the centre of each dish 2 h after plating and again after 24 h,
and expressing the 24 h count as a percentage of the 2 h
count. Analysis of the size and complexity of neurite arbours
was carried out 24 h after plating. The neurite arbours were
labelled either by incubating the neurons with the fluorescent
vital dye calcein AM (Invitrogen) at the end of the experiment
or by transfecting the neurons with a YFP expression plasmid
prior to plating. Transfection was carried out by electro-
poration using the Neon Transfection system (Invitrogen).
Images of neurite arbours were acquired by fluorescence
microscopy, and analysed to obtain total neurite length,
number of branch points and Sholl profiles [37]. Sholl analysis
was carried out at either 30 or 50 mm intervals.
To estimate the relative level of NF-kB transcriptional
activity, neurons were transfected with a plasmid expressing
GFP under the control of an NF-kB promoter, and cultured in
well dishes of 9 mm diameter. Neurons were imaged with a
Zeiss Axioplan confocal microscope 4 and 24 h after transfec-
tion, and the number of GFP-positive neurons per well was
counted. All imaging and quantification was performed
blind. Statistical comparisons were performed by ANOVA
followed by Fisher’s post hoc test.For studying the effects of soluble RANKL on local neur-
ite growth, SCG neurons were seeded in one compartment of
a two-compartment microfluidic device (Xona Microfludics,
CA, USA). The cell body compartment was supplemented
with 10 ng ml21 NGF to sustain neuronal survival, and the
neurite compartment received either NGF alone or NGF
plus RANKL. Calcein AM (Invitrogen) was added to the
neurite compartment 24 h after plating to label neurites in
this compartment and identify the cell bodies that project
neurite into this compartment. Neurite length was quantified
by a modification of a previously described method [38].
Briefly, using NIH IMAGEJ, a grid of vertical lines was traced
with an interline interval of 200 mm. Total intersections
between neurites and the grid were counted and normalized
against the number of labelled somas in the cell body
compartment. Average neurite length per projecting cell
body was calculated using the formula L ¼ DI/2, where L
is the estimated length, D the interline interval and I the
average number of intersections per projecting cell body.
Measurements were independently carried out in 10 separate
fields along the microfluidic barrier.
Purified recombinant NGF, BDNF and RANKL were
obtained from R&D Systems. IKKa, IKKb, S536A-p65 and
IkBaplasmidswere providedbyRonHay (DundeeUniversity).5.3. Western blots
Neurons were plated at high density in polyornithine/laminin-
coated 96-well plates (70 000 neurons per well). The neurons
were incubated overnight in medium containing 10 ngml–1
NGF before treating for different intervals with 10 ng/ml21
RANKL. After treatment, the cells were lysed in RIPA buffer
and insoluble debris was removed by centrifugation. Samples
were transferred to polyvinylidene difluoride membranes
using the Bio-Rad TransBlot. Membranes were blocked with
5 per cent BSA in phosphate-buffered saline (PBS) containing
0.1 per cent TWEEN 20 and incubated with either anti-p65
(1 : 1000; Cell Signalling) or anti-phospho-S536-p65 (1 : 1000;
Cell Signalling) antibodies that were detected with peroxidase-
linked secondary antibodies (1 : 2000; Promega) and ECL-plus
(Amersham). Densitometry was carried out using the GEL-PRO
ANALYZER 32 program (Media Cybernetics, Rockville, MD).5.4. Immunocytochemistry
Cultured neurons were fixed in ice-cold methanol for
10 mins, washed three times with PBS and blocked with
5 per cent BSA in PBS for 1 h at room temperature. The
cells were incubated overnight at 48C with anti-b-III tubulin
(1 : 1000; Promega) and anti-RANK (5 g ml21; R&D Systems)
in 1 per cent BSA. After three washes, the cells were
incubated in Alexa-Fluor-labelled secondary antibodies
(Invitrogen, 1 : 500) for 1 h. Controls (secondary antibody
alone) were included in all studies.6. Acknowledgement
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